Skip to main content

Table 2 Effect of covariate inclusion on the OFV for the atazanavir in hair model

From: A population pharmacokinetic model is beneficial in quantifying hair concentrations of ritonavir-boosted atazanavir: a study of HIV-infected Zimbabwean adolescents

Model

OFV

ΔOFV

Cummulative ΔOFV

Cummulative D.F

Baseline

268.6

–

–

–

Baseline+Occassion

220.8

47.8

47.8

1

Baseline+Occasion+Adherence

202.4

18.4

66.2

2

Baseline+Occasion+ Adherence +BMI

194.9

7.5

73.7

4

Baseline+Occasion+ Adherence VAS + BMI + Guardian

180.9

14.0

87.7

7